News
Energenesis Biomedical, Taiwan Tanabe Collaborate on Diabetic Foot Ulcer Drug
Energenesis and Taiwan Tanabe will collaborate on process technology transfer and manufacturing and controls (CMC) activities to support a potential New Drug Application (NDA) for ENERGI-F703DFU, investigational topical drug for diabetic foot ulcers, in Taiwan.
imphoenix82
- August 7, 2026
- 0 Comments
- 319 Views
-
